InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: None

Thursday, 02/21/2019 12:51:03 PM

Thursday, February 21, 2019 12:51:03 PM

Post# of 41228
Perhaps Zimmer seems to be more concerned with selling stocks than medical science and patient outcome. Their major current threat seems to not be SINT coming down the pipeline with superior product but their own failings of FDA oversight and backlash to their failings of material choices. This threat would exist without SINT's existence. Good thing stocks usually have little to do with reality and reality gets to play catch up. I`m going to speculate SINT is of jovial nature and takes on Zimmer as a customer whenever Zimmer opens the door to that idea in the pursuit of market adoption or patient outcome or whatever. I dont think there's any motivation in SINTS objectives to make sure Zimmer dissolves to take over their market share. Although that sounds tasty if SINT brought in a sociopath CEO. Seems like no timeline exists where it's a good idea to open that ZBH short position in any time frame.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News